Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action
Newshan Behrangi(University of Rostock), Markus Kipp(University of Rostock), Felix Fischbach(Universität Hamburg)
Cited by 97
Related Papers
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
|Med|2024|161